The Effects of LPM570065, a Novel Triple Reuptake Inhibitor, on Extracellular Serotonin, Dopamine and Norepinephrine Levels in Rats

Triple reuptake inhibitors (TRIs) are currently being developed as a new class of promising antidepressants that block serotonin (5-HT), dopamine (DA) and norepinephrine (NE) transporters, thereby increasing extracellular monoamine concentrations. The purpose of this study was to investigate the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Renyu, Li, Xiang, Shi, Yanan, Shao, Yufeng, Sun, Kaoxiang, Wang, Aiping, Sun, Fengying, Liu, Wanhui, Wang, Di, Jin, Jingji, Li, Youxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948889/
https://www.ncbi.nlm.nih.gov/pubmed/24614602
http://dx.doi.org/10.1371/journal.pone.0091775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948889/
https://www.ncbi.nlm.nih.gov/pubmed/24614602
http://dx.doi.org/10.1371/journal.pone.0091775

Ejemplares similares